Virus Biosensors Market

Virus Biosensors Market

  • ICT-SE-6207
  • 4.8 Rating
  • 300 Pages
  • 10-09-2023
  • 68 Reviews
  • Docx PDF
Raksha

Author:

Raksha Sharma

Amulya

Fact-checked by:

Amulya Agarwal

Shruti

Editor:

Shruti Bhat

Market Outlook:

The Global Virus Biosensors Market was estimated at USD 148.49 Million in 2022 and is anticipated to reach USD 261.01 Million by 2031, expanding at a CAGR of 6.6% during the forecast period.

Contamination and infection due to viruses are one of the major reasons for diseases amounting to hundreds of thousands of deaths every year. In recent years, several novels and reemerging viral diseases have seen an outstanding rise in occurrence like coronavirus disease 2019 (COVID-19) which has arguably altered the socioeconomic strata and also pointed out the shortcomings in medical biology and diagnostics at a global scale. Viruses are nonliving obligate parasites and require living host cells to replicate and propagate. Due to their error-prone replication mechanism and fast mutations, the protective layers and mechanisms change quickly, thus helping them to evade immune reactions in the host cell. This has led to reemergence and also establishing new virus strains. Medicinal biology and conventional diagnostic practices are now facing a challenging task to upkeep with the pace of these occurrences.

Virus Biosensors Market Outlook

Therefore, the increasing prevalence of viral diseases and the emergence of new virus strains have highlighted the urgent need for more sensitive, specific, and rapid diagnostic tools. Traditional diagnostic methods, such as culture-based techniques and PCR, can take several days to provide results, which can lead to delayed treatment and increased mortality rates. This has led to a growing demand for virus biosensors, which offer faster, more accurate, and cost-effective diagnostic solutions.

Macro-economic Factors

Healthcare Expenditure

The impact of healthcare expenditure on the global virus biosensors market is significant, as it directly affects the demand for these diagnostic tools. Increasing healthcare expenditure increases e demand for virus biosensors. This is because these devices offer faster, more accurate, and cost-effective diagnostic solutions compared to traditional diagnostic methods. For instance, in 2022, health-care spending in the United States has increased by 4.1 percent to $4.5 trillion, or $13,493 per person. Health spending accounted for 17.3 percent of the nation's Gross Domestic Product. This is expected to positively impact the virus biosensors market.

Population

The virus biosensors market has been significantly influenced by the global increase in population and the aging demographic in many regions. As the global population continues to grow, the incidence of viral diseases is also increasing, leading to a higher demand for virus biosensors. Moreover, as populations become more urbanized and travel more frequently, the risk of viral disease outbreaks also increases. This has led to a growing demand for point-of-care (POC) testing, which allows for rapid and accurate diagnosis of viral diseases in remote or resource-limited settings. For instance, according to United Nations (UN) data, the world's population having more than tripled since the mid-twentieth century. The worldwide human population reached 8.0 billion in mid-November 2022, up from 2.5 billion in 1950. Moreover, world's population is predicted to grow by about 2 billion people during the next 30 years, from 8 billion today to 9.7 billion in 2050, with a peak of nearly 10.4 billion in the mid-2080s.

Market Dynamics

Market Driver- Increasing Viral Infection

Rising viral infections due to vector-borne diseases including dengue, yellow fever, zika, Japan encephalitis are expected to increase demand for virus biosensor during the forecast period. For instance, according to a report of WHO in 2020, Dengue is the most common viral infection spread by Aedes mosquitos. It affects roughly 3.9 billion people in 129 countries, resulting in an estimated 96 million symptomatic cases and 40,000 fatalities every year. Moreover, the pandemic has accelerated the adoption and advancement of biosensors for the diagnosis of COVID-19 and other viruses, leading to the development of innovative and efficient virus detection techniques, including optical biosensors and carbon nanoparticle-based COVID-19 biosensors. Therefore, the virus biosensor market has experienced significant growth and innovation in response to the urgent need for effective and rapid virus detection technologies during the COVID-19 pandemic.

Market Driver- Rising Need for Accurate, Ultrasensitive, Rapid, and Affordable Diagnostic Techniques

The rising need for accurate, ultrasensitive, rapid, and affordable diagnostic techniques has had a significant impact on the virus biosensor market. The COVID-19 pandemic has highlighted the urgent need for rapid and sensitive virus detection technologies, leading to a surge in the development and production of biosensors for the detection and monitoring of viruses, including SARS-CoV-2. The demand for highly sensitive detection against coronaviruses in patient blood samples has led to the development of new biosensor technologies that can detect low viral loads at an early stage. The application and development of diagnostic techniques, particularly biosensors, have been a focus in the context of the COVID-19 pandemic, with efforts directed towards enhancing nanomaterials for rapid, sensitive, and low-cost diagnostics of SARS-CoV-2. The development of biosensors that are rapid, highly accurate, and sensitive is essential for the design and operation of biosensors. The use of nanomaterials in the rapid detection of biosensors has been a significant innovation in the virus biosensor market. Therefore, the rising need for accurate, ultrasensitive, rapid, and affordable diagnostic techniques has driven the growth and innovation of the virus biosensor market, particularly in the context of the COVID-19 pandemic and others viral infections.

Market Restraint- Stringent Regulatory Requirements

Stringent regulatory requirements of different countries are anticipated to restrict the market growth during the forecast period. Regulatory requirements such as the approval process for virus biosensors can take several years, during which time companies may incur significant costs without any revenue. This could make it challenging for companies to secure funding and invest in research and development. Additionally, change in the regulatory requirements, which could make it difficult for companies to predict the cost and timeline of regulatory approval. This could create uncertainty around the commercial viability of virus biosensors and discourage investment in research and development.

Market Opportunity- Growing Healthcare Sector in Emerging Markets

As healthcare infrastructure improves in emerging markets, there is a growing demand for rapid and accurate virus detection methods. This presents a significant opportunity for virus biosensor marketers to meet this demand with innovative and effective products. While virus biosensors are currently used primarily in clinical settings, there is potential for their expansion into other areas, such as environmental monitoring, food safety, and water quality testing, in emerging markets. This presents a significant opportunity for virus biosensor manufacturers to explore new applications and expand their customer base in these markets. Emerging markets often have lower healthcare spending per capita than developed markets, which can make cost-effective solutions more attractive. Virus biosensors that offer lower costs or higher sensitivity may be more appealing to healthcare providers and patients in these markets, which could drive demand for these products.

Scope of the Report

The report on the global virus biosensors market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Virus Biosensors Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

By Biosensor Technology Type (Electrochemical Biosensors, Physical Biosensors, Optical Biosensors, Enzyme Biosensor, DNA Biosensor, and Others), By Application (Point-Of-Care Testing (POCT), Research Laboratory, Home Diagnostics, Environmental Testing, Biodefence, and Others), By End-User (Clinical Diagnostic Laboratories, Hospitals, Research Laboratories, and Others)

Regional Scope

Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered

Creative Biolabs.; CANATU; Conductive Technologies; Menon Biosensors Inc.; PalmSens; Sartorius AG; Zimmer; and Peacock.

 

Segmental Outlook

Based on biosensor technology type, the global virus biosensors market is segmented into electrochemical biosensors, physical biosensors, optical biosensors, enzyme biosensor, DNA biosensor, and others. The electrochemical biosensors segment held a major share of the market in 2022 and is expected to expand at a notable CAGR during the forecast period. This is because of the electrochemical biosensors offer high sensitivity and specificity, which makes them ideal for detecting low concentrations of target analytes in complex matrices.

Virus Biosensors Market Biosensor Technology Type

Based on application, the global virus biosensors market is segmented into point-of-care testing (POCT), research laboratory, home diagnostics, environmental testing, biodefence, and others. The point-of-care testing (POCT) segment held a significant share of the market in 2022 and is expected to expand at a weighty CAGR during the forecast period. Since POCT allows for faster diagnosis and treatment of diseases and medical conditions, as test results are available quickly, often within minutes or hours. This is particularly important in emergency situations, where timely diagnosis and treatment can mean the difference between life and death.

Virus Biosensors Market Applications

Based on the end-user, the global virus biosensors market is segregated into clinical diagnostic laboratories, hospitals, research laboratories, and others. The hospitals segment held notable share of the market in 2022. As the COVID-19 pandemic has shown, viral outbreaks can lead to a significant increase in demand for testing. Hospitals that are equipped with virus biosensors may be better positioned to meet this demand, as they can offer faster and more accurate test results than traditional laboratory facilities. This increased demand for testing can lead to higher revenue for hospitals.

Virus Biosensors Market End User

Regional Outlook

On the basis of region, the global retirement community market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa (MEA).

The global virus biosensors market in North America is estimated to expand at a noteworthy CAGR during the forecast period. North America, especially the United States, has a leading position in the biosensor for virus detection market due to its advanced technology and extensive biomedical research activities. The increasing lifestyle-related diseases in the region has urged the need for point-of-care testing devices, thereby driving the biosensor industry. There is also a significant demand for virus detection, thus propelling market growth. Moreover, the presence of well-established healthcare infrastructure and increasing investment in healthcare are other vital factors contributing to market expansion.

Virus Biosensors Market Regions

Key Developments

  • In January 2023, SD Biosensor (SDB) and SJL Partners acquired Meridian Bioscience, an U.S. based diagnostic products manufacturer.

Key Benefits for Industry Participants & Stakeholders

  • In-depth Analysis of the Global Virus Biosensors Market

  • Historical, Current, and Projected Market Size in Terms of Value

  • Potential & Niche Segments and Regions Exhibiting Promising Growth Covered

  • Industry Drivers, Restraints, and Opportunities Covered in the Study

  • Recent Industry Trends and Developments

  • Competitive Landscape & Strategies of Key Players

Segments

By Biosensor Technology Type

  • Electrochemical Biosensors
  • Physical Biosensors
  • Optical Biosensors
  • Enzyme Biosensor
  • DNA Biosensor
  • Others

By Application

  • Point-Of-Care Testing (POCT)
  • Research Laboratory
  • Home Diagnostics
  • Environmental Testing
  • Biodefence
  • Others

By End-user

  • Clinical Diagnostic Laboratories
  • Hospitals
  • Research Laboratories
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key Market Players Profiled in the Report

  • Creative Biolabs
  • CANATU
  • Conductive Technologies
  • Menon Biosensors Inc.
  • PalmSens, Sartorius AG
  • Zimmer and Peacock

Competitive Landscape

  • Key players operating in the global virus biosensors market are Creative Biolabs., CANATU, Conductive Technologies, Menon Biosensors Inc., PalmSens, Sartorius AG, Zimmer and Peacock.

  • Market players are pursuing strategies such as acquisitions, product launches, collaborations, and geographic expansion to leverage untapped opportunities in the Global Virus Biosensors Market.

    Virus Biosensors Market Key Players

Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Virus Biosensors Market Overview
   4.1 Introduction
      4.1.1 Market Taxonomy
      4.1.2 Market Definition
      4.1.3 Macro-Economic Factors Impacting the Market Growth
   4.2 Virus Biosensors Market Dynamics
      4.2.1 Market Drivers
      4.2.2 Market Restraints
      4.2.3 Market Opportunity
   4.3 Virus Biosensors Market - Supply Chain Analysis
      4.3.1 List of Key Suppliers
      4.3.2 List of Key Distributors
      4.3.3 List of Key Consumers
   4.4 Key Forces Shaping the Virus Biosensors Market
      4.4.1 Bargaining Power of Suppliers
      4.4.2 Bargaining Power of Buyers
      4.4.3 Threat of Substitution
      4.4.4 Threat of New Entrants
      4.4.5 Competitive Rivalry
   4.5 Global Virus Biosensors Market Size & Forecast, 2016-2031
      4.5.1 Virus Biosensors Market Size and Y-o-Y Growth
      4.5.2 Virus Biosensors Market Absolute $ Opportunity
   4.6 Global Virus Biosensors Market: Impact Of Key Regulations
   4.7 Biosensors for the detection of respiratory viruses: Outlook
   4.8 Patent Analysis
   4.9 Investment Scenario
   4.10 Global Biosensors Market: Overview
   4.11 Recent Advances in Electrochemical Biosensors: Applications, Challenges, and Future Scope
   4.12 Healthcare Expenditure
   4.13 Disease Epidemiology Outlook
   4.14 Medical Diagnostic Devices Market Overview
Chapter 5 Global Virus Biosensors Market Analysis and Forecast By Biosensor Technology Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities By Biosensor Technology Type
      5.1.2 Basis Point Share (BPS) Analysis By Biosensor Technology Type
      5.1.3 Absolute $ Opportunity Assessment By Biosensor Technology Type
   5.2 Virus Biosensors Market Size Forecast By Biosensor Technology Type
      5.2.1 Electrochemical Biosensors
      5.2.2 Physical Biosensor
         5.2.2.1 Piezoelectric Biosensors
         5.2.2.2 Thermometric Biosensors
      5.2.3 Optical Biosensors
      5.2.4 Enzyme Biosensor
      5.2.5 DNA Biosensor
      5.2.6 Others
   5.3 Market Attractiveness Analysis By Biosensor Technology Type
Chapter 6 Global Virus Biosensors Market Analysis and Forecast By Application
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities By Application
      6.1.2 Basis Point Share (BPS) Analysis By Application
      6.1.3 Absolute $ Opportunity Assessment By Application
   6.2 Virus Biosensors Market Size Forecast By Application
      6.2.1 Point-of-Care Testing (POCT)
      6.2.2 Research Laboratory
      6.2.3 Home Diagnostics
      6.2.4 Environmental Testing
      6.2.5 Biodefence
      6.2.6 Others
   6.3 Market Attractiveness Analysis By Application
Chapter 7 Global Virus Biosensors Market Analysis and Forecast By End-user
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities By End-user
      7.1.2 Basis Point Share (BPS) Analysis By End-user
      7.1.3 Absolute $ Opportunity Assessment By End-user
   7.2 Virus Biosensors Market Size Forecast By End-user
      7.2.1 Clinical Diagnostic Laboratories
      7.2.2 Hospitals
      7.2.3 Research Laboratories
      7.2.4 Others
   7.3 Market Attractiveness Analysis By End-user
Chapter 8 Global Virus Biosensors Market Analysis and Forecast by Region
   8.1 Introduction
      8.1.1 Key Market Trends & Growth Opportunities by Region
      8.1.2 Basis Point Share (BPS) Analysis by Region
      8.1.3 Absolute $ Opportunity Assessment by Region
   8.2 Virus Biosensors Market Size Forecast by Region
      8.2.1 North America
      8.2.2 Europe
      8.2.3 Asia Pacific
      8.2.4 Latin America
      8.2.5 Middle East & Africa (MEA)
   8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
   9.1 Introduction
   9.2 Current & Future Impact Analysis
   9.3 Economic Impact Analysis
   9.4 Government Policies
   9.5 Investment Scenario
Chapter 10 North America Virus Biosensors Analysis and Forecast
   10.1 Introduction
   10.2 North America Virus Biosensors Market Size Forecast by Country
      10.2.1 U.S.
      10.2.2 Canada
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 North America Virus Biosensors Market Size Forecast By Biosensor Technology Type
      10.6.1 Electrochemical Biosensors
      10.6.2 Physical Biosensor
         10.6.2.1 Piezoelectric Biosensors
         10.6.2.2 Thermometric Biosensors
      10.6.3 Optical Biosensors
      10.6.4 Enzyme Biosensor
      10.6.5 DNA Biosensor
      10.6.6 Others
   10.7 Basis Point Share (BPS) Analysis By Biosensor Technology Type
   10.8 Absolute $ Opportunity Assessment By Biosensor Technology Type
   10.9 Market Attractiveness Analysis By Biosensor Technology Type
   10.10 North America Virus Biosensors Market Size Forecast By Application
      10.10.1 Point-of-Care Testing (POCT)
      10.10.2 Research Laboratory
      10.10.3 Home Diagnostics
      10.10.4 Environmental Testing
      10.10.5 Biodefence
      10.10.6 Others
   10.11 Basis Point Share (BPS) Analysis By Application
   10.12 Absolute $ Opportunity Assessment By Application
   10.13 Market Attractiveness Analysis By Application
   10.14 North America Virus Biosensors Market Size Forecast By End-user
      10.14.1 Clinical Diagnostic Laboratories
      10.14.2 Hospitals
      10.14.3 Research Laboratories
      10.14.4 Others
   10.15 Basis Point Share (BPS) Analysis By End-user
   10.16 Absolute $ Opportunity Assessment By End-user
   10.17 Market Attractiveness Analysis By End-user
Chapter 11 Europe Virus Biosensors Analysis and Forecast
   11.1 Introduction
   11.2 Europe Virus Biosensors Market Size Forecast by Country
      11.2.1 Germany
      11.2.2 France
      11.2.3 Italy
      11.2.4 U.K.
      11.2.5 Spain
      11.2.6 Russia
      11.2.7 Rest of Europe
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Europe Virus Biosensors Market Size Forecast By Biosensor Technology Type
      11.6.1 Electrochemical Biosensors
      11.6.2 Physical Biosensor
         11.6.2.1 Piezoelectric Biosensors
         11.6.2.2 Thermometric Biosensors
      11.6.3 Optical Biosensors
      11.6.4 Enzyme Biosensor
      11.6.5 DNA Biosensor
      11.6.6 Others
   11.7 Basis Point Share (BPS) Analysis By Biosensor Technology Type
   11.8 Absolute $ Opportunity Assessment By Biosensor Technology Type
   11.9 Market Attractiveness Analysis By Biosensor Technology Type
   11.10 Europe Virus Biosensors Market Size Forecast By Application
      11.10.1 Point-of-Care Testing (POCT)
      11.10.2 Research Laboratory
      11.10.3 Home Diagnostics
      11.10.4 Environmental Testing
      11.10.5 Biodefence
      11.10.6 Others
   11.11 Basis Point Share (BPS) Analysis By Application
   11.12 Absolute $ Opportunity Assessment By Application
   11.13 Market Attractiveness Analysis By Application
   11.14 Europe Virus Biosensors Market Size Forecast By End-user
      11.14.1 Clinical Diagnostic Laboratories
      11.14.2 Hospitals
      11.14.3 Research Laboratories
      11.14.4 Others
   11.15 Basis Point Share (BPS) Analysis By End-user
   11.16 Absolute $ Opportunity Assessment By End-user
   11.17 Market Attractiveness Analysis By End-user
Chapter 12 Asia Pacific Virus Biosensors Analysis and Forecast
   12.1 Introduction
   12.2 Asia Pacific Virus Biosensors Market Size Forecast by Country
      12.2.1 China
      12.2.2 Japan
      12.2.3 South Korea
      12.2.4 India
      12.2.5 Australia
      12.2.6 South East Asia (SEA)
      12.2.7 Rest of Asia Pacific (APAC)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Asia Pacific Virus Biosensors Market Size Forecast By Biosensor Technology Type
      12.6.1 Electrochemical Biosensors
      12.6.2 Physical Biosensor
         12.6.2.1 Piezoelectric Biosensors
         12.6.2.2 Thermometric Biosensors
      12.6.3 Optical Biosensors
      12.6.4 Enzyme Biosensor
      12.6.5 DNA Biosensor
      12.6.6 Others
   12.7 Basis Point Share (BPS) Analysis By Biosensor Technology Type
   12.8 Absolute $ Opportunity Assessment By Biosensor Technology Type
   12.9 Market Attractiveness Analysis By Biosensor Technology Type
   12.10 Asia Pacific Virus Biosensors Market Size Forecast By Application
      12.10.1 Point-of-Care Testing (POCT)
      12.10.2 Research Laboratory
      12.10.3 Home Diagnostics
      12.10.4 Environmental Testing
      12.10.5 Biodefence
      12.10.6 Others
   12.11 Basis Point Share (BPS) Analysis By Application
   12.12 Absolute $ Opportunity Assessment By Application
   12.13 Market Attractiveness Analysis By Application
   12.14 Asia Pacific Virus Biosensors Market Size Forecast By End-user
      12.14.1 Clinical Diagnostic Laboratories
      12.14.2 Hospitals
      12.14.3 Research Laboratories
      12.14.4 Others
   12.15 Basis Point Share (BPS) Analysis By End-user
   12.16 Absolute $ Opportunity Assessment By End-user
   12.17 Market Attractiveness Analysis By End-user
Chapter 13 Latin America Virus Biosensors Analysis and Forecast
   13.1 Introduction
   13.2 Latin America Virus Biosensors Market Size Forecast by Country
      13.2.1 Brazil
      13.2.2 Mexico
      13.2.3 Rest of Latin America (LATAM)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Latin America Virus Biosensors Market Size Forecast By Biosensor Technology Type
      13.6.1 Electrochemical Biosensors
      13.6.2 Physical Biosensor
         13.6.2.1 Piezoelectric Biosensors
         13.6.2.2 Thermometric Biosensors
      13.6.3 Optical Biosensors
      13.6.4 Enzyme Biosensor
      13.6.5 DNA Biosensor
      13.6.6 Others
   13.7 Basis Point Share (BPS) Analysis By Biosensor Technology Type
   13.8 Absolute $ Opportunity Assessment By Biosensor Technology Type
   13.9 Market Attractiveness Analysis By Biosensor Technology Type
   13.10 Latin America Virus Biosensors Market Size Forecast By Application
      13.10.1 Point-of-Care Testing (POCT)
      13.10.2 Research Laboratory
      13.10.3 Home Diagnostics
      13.10.4 Environmental Testing
      13.10.5 Biodefence
      13.10.6 Others
   13.11 Basis Point Share (BPS) Analysis By Application
   13.12 Absolute $ Opportunity Assessment By Application
   13.13 Market Attractiveness Analysis By Application
   13.14 Latin America Virus Biosensors Market Size Forecast By End-user
      13.14.1 Clinical Diagnostic Laboratories
      13.14.2 Hospitals
      13.14.3 Research Laboratories
      13.14.4 Others
   13.15 Basis Point Share (BPS) Analysis By End-user
   13.16 Absolute $ Opportunity Assessment By End-user
   13.17 Market Attractiveness Analysis By End-user
Chapter 14 Middle East & Africa (MEA) Virus Biosensors Analysis and Forecast
   14.1 Introduction
   14.2 Middle East & Africa (MEA) Virus Biosensors Market Size Forecast by Country
      14.2.1 Saudi Arabia
      14.2.2 South Africa
      14.2.3 UAE
      14.2.4 Rest of Middle East & Africa (MEA)
   14.3 Basis Point Share (BPS) Analysis by Country
   14.4 Absolute $ Opportunity Assessment by Country
   14.5 Market Attractiveness Analysis by Country
   14.6 Middle East & Africa (MEA) Virus Biosensors Market Size Forecast By Biosensor Technology Type
      14.6.1 Electrochemical Biosensors
      14.6.2 Physical Biosensor
         14.6.2.1 Piezoelectric Biosensors
         14.6.2.2 Thermometric Biosensors
      14.6.3 Optical Biosensors
      14.6.4 Enzyme Biosensor
      14.6.5 DNA Biosensor
      14.6.6 Others
   14.7 Basis Point Share (BPS) Analysis By Biosensor Technology Type
   14.8 Absolute $ Opportunity Assessment By Biosensor Technology Type
   14.9 Market Attractiveness Analysis By Biosensor Technology Type
   14.10 Middle East & Africa (MEA) Virus Biosensors Market Size Forecast By Application
      14.10.1 Point-of-Care Testing (POCT)
      14.10.2 Research Laboratory
      14.10.3 Home Diagnostics
      14.10.4 Environmental Testing
      14.10.5 Biodefence
      14.10.6 Others
   14.11 Basis Point Share (BPS) Analysis By Application
   14.12 Absolute $ Opportunity Assessment By Application
   14.13 Market Attractiveness Analysis By Application
   14.14 Middle East & Africa (MEA) Virus Biosensors Market Size Forecast By End-user
      14.14.1 Clinical Diagnostic Laboratories
      14.14.2 Hospitals
      14.14.3 Research Laboratories
      14.14.4 Others
   14.15 Basis Point Share (BPS) Analysis By End-user
   14.16 Absolute $ Opportunity Assessment By End-user
   14.17 Market Attractiveness Analysis By End-user
Chapter 15 Competition Landscape
   15.1 Virus Biosensors Market: Competitive Dashboard
   15.2 Global Virus Biosensors Market: Market Share Analysis, 2022
   15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
      15.3.1 CANATU
      15.3.2 Conductive Technologies
      15.3.3 Creative Biolabs
      15.3.4 Merck KGaA,
      15.3.5 PalmSens
      15.3.6 Sartorius AG

Purchase Premium Report

FAQ Section

Some frequently asked quetions about this report!

The base year considered for the Global Virus Biosensors Market report is 2022. The complete analysis period is 2016 to 2031, wherein, 2016 to 2021 are the historic years, and the forecast is provided from 2023 to 2031.

The forecast year considered for the Global Virus Biosensors Market report is 2031.

Factors such as stringent regulation is expected to hinder the market.

The COVID-19 pandemic has had a significant impact on the virus biosensor market. The demand for rapid and sensitive virus detection technologies has increased, leading to a surge in the development and production of biosensors for the detection and monitoring of viruses, including SARS-CoV-2. Researchers, laboratories, universities, and companies around the world have been working to develop and produce much-needed test kits, leading to continuous innovation in biosensing technologies. The application and development of diagnostic techniques, particularly biosensors, have been a focus in the context of the COVID-19 pandemic, with efforts directed towards enhancing nanomaterials for rapid, sensitive, and low-cost diagnostics of SARS-CoV-2.

Major players include Creative Biolabs., CANATU, Conductive Technologies, Menon Biosensors Inc., PalmSens, Sartorius AG, Zimmer and Peacock.

Factors such as growing population and healthcare expenditure impact are analyzed in the final report.

According to this Growth Market Reports report, the Global Virus Biosensors Market is likely to register a CAGR of 6.6% during the forecast period 2023-2031, with a projected valuation of USD 261.01 billion by the end of 2031.

Increasing Viral Infection and Rising Need for Accurate, Ultrasensitive, Rapid, And Affordable Diagnostic Techniques are the factors expected to drive the market growth during the forecast period.

Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.

Additional company profiles can be provided on request. For a discussion related to the above findings, click Speak to Analyst